RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
63 hedge funds and large institutions have $109M invested in Regulus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
26% less capital invested
Capital invested by funds: $147M → $109M (-$37.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
63
Holding in Top 10
1
Calls
$329K
Puts
$119K
Top Buyers
| 1 | +$7.61M | |
| 2 | +$6.96M | |
| 3 | +$5.91M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.33M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.09M |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$3M | |
| 3 | -$1.79M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.61M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.54M |